Gland Pharma Limited (GLAND) — Announcement

· NSE Neutral
📢 Key Event
Gland Pharma announces investor meeting schedule
💡 Investor Takeaway
Investors should note these meetings may influence near-term sentiment but carry no guaranteed market impact.

Gland Pharma announced its schedule of upcoming analyst and institutional investor meetings, listing one-on-one sessions with Haitong Securities, ICICI Securities, Midas Research, and Sohum Asset on June 9-11, 2026. The notice emphasizes these meetings are subject to change due to operational exigencies and serves as a formal disclosure to stock exchanges under SEBI regulations.

📄 View Original Announcement (PDF)

About Gland Pharma Limited (GLAND)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹30,781.44 Cr P/E: 43.7

View full GLAND stock details →

📡 Get AI alerts when GLAND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GLAND — Free

📊 More GLAND filings

See all GLAND filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when GLAND files new disclosures

Track GLAND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GLAND — Free

Free account · 2 AI queries/day